XML 41 R28.htm IDEA: XBRL DOCUMENT
v3.25.2

Total Equity | 9 Months Ended
--- | ---
Aug. 31, 2025
Equity [Abstract] |
Total Equity | Note 17. Total Equity Common Stock At August 31, 2025 and November 30, 2024, we had 565,000,000 authorized shares of voting common stock with a par value of $1.00 per share. At August 31, 2025 and November 30, 2024, we had outstanding 206,280,296 and 205,504,272 common shares outstanding, respectively. The Board of Directors has authorized the repurchase of common stock up to $250.0 million under a share repurchase program. Treasury stock repurchases during the three and nine months ended August 31, 2025 represent repurchases of common stock for net-share tax withholding under our equity compensation plan. Non-Voting Convertible Preferred Shares On April 27, 2023, we established Series B Non-Voting Convertible Preferred Shares with a par value of $1.00 per share (“Series B Preferred Stock”) and designated 70,000 shares as Series B Preferred Stock. The Series B Preferred Stock has a liquidation preference of $17,500 per share and rank senior to our voting common stock upon dissolution, liquidation or winding up of Jefferies Financial Group Inc. Each share of Series B Preferred Stock is automatically convertible into 500 shares of non-voting common stock, subject to certain anti-dilution adjustments, three years after issuance. The Series B Preferred Stock participates in cash dividends and distributions alongside our voting common stock on an as-converted basis. Additionally, on April 27, 2023, we entered into an Exchange Agreement with Sumitomo Mitsui Banking Corporation (“SMBC”), which entitles SMBC to exchange shares of our voting common stock for shares of the Series B Preferred Stock at a rate of 500 shares of voting common stock for one share of Series B Preferred Stock. The Exchange Agreement is limited to 55,125 shares of Preferred Stock and SMBC will pay $1.50 per share of voting common stock so exchanged. As of November 30, 2024, SMBC had cumulatively exchanged approximately 27.6 million shares of voting common stock for 55,125 shares of Series B Preferred Stock. Following this exchange, SMBC increased its ownership of our common stock on an as-converted basis and fully-diluted, as-converted basis. As a result, the CEO of Sumitomo Mitsui Financial Group, Inc. was elected and now serves on our Board of Directors. On September 19, 2024, SMBC purchased 9.2 million shares of our common stock. At August 31, 2025, SMBC owns approximately 15.7% of our common stock on an as-converted basis and 14.5% on a fully-diluted, as-converted basis. Refer to Note 22, Related Party Transactions for further information regarding transactions with SMBC. On September 19, 2025, our Board of Directors established Series B-1 Non-Voting Convertible Preferred Shares with a par value of $1.00 per share (“Series B-1 Preferred Stock”) and designated 17,500 shares as Series B-1 Preferred Stock. The Series B-1 Preferred Stock has a liquidation preference of $500 per share and ranks senior to our voting common stock and equal to the Series B Preferred Stock upon dissolution, liquidation or winding up of Jefferies Financial Group Inc. Each share of Series B-1 Preferred Stock is automatically convertible into 500 shares of non-voting common stock as soon as such non-voting common stock exists, subject to certain anti-dilution adjustments. The Series B-1 Preferred Stock also participates in cash dividends and distributions alongside our voting common stock on an as- converted basis. Additionally, on September 19, 2025, we entered into an amended and restated Exchange Agreement (the “Amended and Restated Exchange Agreement”) with SMBC, which entitles SMBC to exchange shares of our voting common stock for shares of the Series B-1 Preferred Stock at a rate of 500 shares of voting common stock for one share of Series B-1 Preferred Stock. The Amended and Restated Exchange Agreement is limited to 17,500 shares of Series B-1 Preferred Stock. Under the Amended and Restated Exchange Agreement, SMBC is permitted to increase its economic ownership in the Company to up to 20% on an as- converted and fully diluted basis, while continuing to own less than 5% of a voting interest in the Company. Earnings Per Common Share Basic and diluted earnings per common share amounts were calculated by dividing net earnings by the weighted-average number of common shares outstanding. The numerators and denominators used to calculate basic and diluted earnings per common share are as follows:
| Three Months Ended August 31, | Nine Months Ended August 31,
In thousands, except per share amounts | 2025 | 2024 | 2025 | 2024
Numerator for earnings per common share from continuing operations: |  |  |  |
Net earnings from continuing operations ........................................................................................... | $242,504 | $174,676 | $470,748 | $493,606
Less: Net losses attributable to noncontrolling interests ................................................................. | (10,041) | (6,304) | (24,692) | (16,541)
Allocation of earnings to participating securities (1) ........................................................................ | (28,559) | (20,785) | (55,528) | (48,501)
Net earnings from continuing operations attributable to common shareholders for basic earnings per share ............................................................................................................................. | $223,986 | $160,195 | $439,912 | $461,646
Net earnings from continuing operations attributable to common shareholders for diluted earnings per share ............................................................................................................................. | $223,986 | $160,195 | $439,912 | $461,646
Numerator for earnings per common share from discontinued operations: |  |  |  |
Net earnings (losses) from discontinued operations, net of taxes ................................................. | — | 6,363 | — | (1,488)
Less: Net losses attributable to noncontrolling interests ................................................................. | — | (570) | — | (2,561)
Net earnings (losses) from discontinued operations attributable to common shareholders for basic and diluted earnings per share ....................................................................................... | $— | $6,933 | $— | $1,073
Net earnings attributable to common shareholders for basic earnings per share ..................... | $223,986 | $167,128 | $439,912 | $462,719
Net earnings attributable to common shareholders for diluted earnings per share .................. | $223,986 | $167,128 | $439,912 | $462,719
Denominator for earnings per common share: |  |  |  |
Weighted average common shares outstanding ............................................................................... | 206,272 | 206,418 | 206,191 | 209,997
Weighted average shares of restricted stock outstanding with future service required ............. | (2,224) | (2,305) | (2,259) | (2,346)
Weighted average RSUs outstanding with no future service required ............................................ | 11,245 | 10,339 | 11,045 | 10,455
Weighted average basic common shares .......................................................................................... | 215,293 | 214,452 | 214,977 | 218,106
Stock options and other share-based awards ................................................................................... | 4,643 | 4,189 | 4,915 | 3,369
Senior executive compensation plan RSU awards ............................................................................ | 2,779 | 3,058 | 2,647 | 2,705
Weighted average diluted common shares (2) ................................................................................. | 222,715 | 221,699 | 222,539 | 224,180
Earnings per common share: |  |  |  |
Basic from continuing operations ........................................................................................................ | $1.04 | $0.75 | $2.05 | $2.12
Basic from discontinued operations .................................................................................................... | — | 0.03 | — | —
Basic ......................................................................................................................................................... | $1.04 | $0.78 | $2.05 | $2.12
Diluted from continuing operations ...................................................................................................... | $1.01 | $0.72 | $1.98 | $2.06
Diluted from discontinued operations .................................................................................................. | — | 0.03 | — | —
Diluted ...................................................................................................................................................... | $1.01 | $0.75 | $1.98 | $2.06
(1)Represents dividends declared during the period on participating securities plus an allocation of undistributed earnings to participating securities. Net losses are not allocated to participating securities. Participating securities represent certain preferred stock, restricted stock and RSUs for which requisite service has not yet been rendered and amounted to weighted average shares of 27.6 million for both the three and nine months ended August 31, 2025, respectively, compared with 26.3 million and 22.9 million for the three and nine months ended August 31, 2024, respectively. Undistributed earnings are allocated to participating securities based upon their right to share in earnings if all earnings for the period had been distributed. (2)Certain securities have been excluded as they would be antidilutive. However, these securities could potentially dilute earnings per share in the future. Antidilutive shares at August 31, 2025 and was 13.4% of the weighted average common shares outstanding for both the three and nine months ended August 31, 2025. Dividends
Nine Months Ended August 31, 2025
Declaration Date | Record Date | Payment Date | Per Common Share Amount
January 8, 2025 | February 14, 2025 | February 27, 2025 | $0.40
March 26, 2025 | May 19, 2025 | May 29, 2025 | $0.40
June 25, 2025 | August 18, 2025 | August 29, 2025 | $0.40
Nine Months Ended August 31, 2024
Declaration Date | Record Date | Payment Date | Per Common Share Amount
January 8, 2024 | February 16, 2024 | February 27, 2024 | $0.30
March 27, 2024 | May 20, 2024 | May 30, 2024 | $0.30
June 26, 2024 | August 19, 2024 | August 30, 2024 | $0.35
On January 8, 2025, the Board of Directors increased our quarterly dividend from $0.35 to $0.40 per common share. On September 29, 2025, the Board of Directors declared a dividend of $0.40 per common share to be paid on November 26, 2025 to common shareholders of record at November 17, 2025. During the three and nine months ended August 31, 2025, we paid cash dividends of $11.0 million and $33.1 million, compared to $9.6 million and $22.2 million for the three and nine months ended August 31, 2024, respectively, to the Series B Preferred stockholder. The payment of dividends is subject to the discretion of our Board of Directors and depends upon general business conditions and other factors that our Board of Directors may deem to be relevant. Accumulated Other Comprehensive Income (Loss)
$ in thousands | August 31, 2025 | November 30, 2024
Net unrealized losses on available-for-sale securities ....................................................................... | $(2,145) | $(2,406)
Net currency translation adjustments and other ..... | (134,748) | (173,841)
Net unrealized losses related to instrument- specific credit risk ....................................................... | (198,719) | (206,664)
Net minimum pension liability .................................... | (39,315) | (40,220)
Total accumulated other comprehensive loss, net of tax .............................................................................. | $(374,927) | $(423,131)
Amounts reclassified out of accumulated other comprehensive income (loss) to net earnings:
| Three Months Ended August 31, | Nine Months Ended August 31,
$ in thousands | 2025 | 2024 | 2025 | 2024
Net unrealized gains on instrument- specific credit risk at fair value (1) ............ | $2,304 | $150 | $9,962 | $2,783
Amortization of defined benefit pension plan actuarial losses (2) .............................. | (124) | (67) | (950) | (247)
Total reclassifications for the period, net of tax ....................................................... | $2,180 | $83 | $9,012 | $2,536
(1)The amounts include income tax expense of $0.8 million and $3.4 million for the three and nine months ended August 31, 2025, respectively, compared with income tax expense of $0.1 million and $1.0 million for the three and nine months ended August 31, 2024, respectively, which were reclassified to Principal transactions revenues. (2)The amounts include income tax benefit of $0.3 million for nine months ended August 31, 2025, compared with an income tax benefit of $0.1 million for the nine months ended August 31, 2024, which were reclassified to Compensation and benefits expenses.

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for equity. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 8A -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (h) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 235 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 235 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 505 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org/1943274/2147478448/946-505-50-6 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 40 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480237/815-40-50-6 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1 Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/505/tableOfContent Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (g) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14 Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14 Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 16 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-16 Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18 Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18 Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18 + Details
Name: | us-gaap_StockholdersEquityNoteDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration